Dose Intensified Molecular Targeted Radiotherapy for Cancer—Lymphoma as a Paradigm
To access this article, please choose from the options below
Supported by National Cancer Institute PO1-CA47829.
PII: S0001-2998(09)00103-2
doi:10.1053/j.semnuclmed.2009.10.005
© 2010 Published by Elsevier Inc.
